https://doi.org/10.4081/mem.2003.666
Norlevo and conscience objection.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The authorisation of the marketing, in Italy, of Norlevo (levonorgestrel) as emergency contraception method (Decree AIC/UAC n. 510/2000 of 26.9.2000) has risen an intense debate on the physician that doesn't want to prescribe drugs, that can hinder the pursuance of the development of the conceived, for deontological and ethical reasons. Besides, it is argued if this decision can fall within the circumstance foreseen by the art. 9 of the Italian Act 194/78 on voluntary abortion about conscience objection.
To give an answer to this question, it is necessary - first of all - to study the mechanism of action of the levonorgestrel: only if there is the possibility of an abortive effect, it would have been possible to appeal to the aforesaid act. The specific juridical reflection is analysed, since the authors conclude that, close to the contraceptive effect, there is also present an effect on postfertilization.
In the light of the Italian Law and of the decisions of the Italian Constitutional Court, the physician refusal to prescribe the Norlevo fall within the forecasts of the art. 9 of the Act 194/78, but also if this would not be recognized, it is always justifiable, in front of the good of human life, a clause of conscience on the grounds of the physician's right to act according to own beliefs.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.